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The aminoacyl-tRNA synthetases (aaRS)2 are a ubiquitous and essential protein family required for protein synthesis (1–3). Structurally and
functionally the aaRSs are divided into two unrelated but biochemically
analogous groups, class I and class II (4 – 6). The aaRSs attach amino
acids to the 3⬘-ends of tRNA containing the corresponding anticodon
sequence, and the resulting aminoacyl-tRNAs (aa-tRNAs) are used as
substrates for ribosomal translation of mRNA. The accuracy of
aa-tRNA synthesis is generally assured by the existence of aaRSs specific
for each particular amino acid-tRNA pair. Cognate tRNA recognition
and discrimination of non-cognate RNAs are achieved by sequencespecific direct and indirect readout of the numerous combinations of
bases present in tRNAs (7–10). The relative structural simplicity and
inherent similarity between the amino acid substrates makes their accurate recognition and discrimination more challenging. Although some
amino acids such as cysteine and tyrosine are different enough to allow
their specific recognition by a particular aaRS (11, 12), others such as
valine and isoleucine are less easily distinguished. For example the class
I aaRS isoleucyl-tRNA synthetase (IleRS) is only able to poorly discriminate against valine, which has a misactivation rate of about 1:200 compared with the cognate substrate isoleucine. Despite this significant rate
of misactivation and misaminoacylation, the accuracy of translation is
not compromised because of the existence of an intrinsic proofreading
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and editing mechanism in IleRS that specifically hydrolyzes both misactivated Val-AMP and misaminoacylated Val-tRNAIle (13, 14). In addition to IleRS, many other class I and class II aaRSs also employ editing to
prevent release of non-cognate aa-tRNA and subsequent loss of translational accuracy (reviewed in Refs. 15 and 16). With a few notable
exceptions (17), editing generally occurs in specialized domains distal
from the active site such as the class I-specific CP1 region of IleRS and
leucyl-, and valyl-tRNA synthetases. The editing domains of class II
aaRSs are more diverse than their class I counterparts and include the
“HXXXH” domain found in both alanyl- (18) and threonyl-tRNA synthetases (ThrRS) (19), an unrelated domain in archaeal ThrRS (20, 21),
the Ybak-like domain in prolyl-tRNA synthetase (ProRS) (22–24), and
the B3/B4 domain of phenylalanyl-tRNA synthetase (PheRS) (25).
The editing domains of aaRSs are normally found in the same subunit
as the active site, the only known exceptions being PheRS and certain
examples of ProRS and ThrRS. PheRS is normally an (␣␤)2 heterotetramer, with the active site located in the ␣-subunit and tRNA binding
sites in both subunits. Recent studies in bacteria revealed that hydrolysis
of misaminoacylated Tyr-tRNAPhe occurs at an editing site in the
␤-subunit ⬃40 Å from the active site (25). This editing site, at the
boundary of the B3 and B4 subdomains, is highly conserved in bacterial
PheRSs and aligns with a divergent domain conserved in eukaryotic and
archaeal sequences that is believed to participate in proofreading. It is
less clear whether mitochondrial PheRSs also have the potential to edit
misacylated tRNAs, as they are monomers and thus lack the conventional (␣␤)2 oligomeric form (26, 27). Mitochondrial PheRS sequences
are most closely related to the bacterial type, being chimeras of the
␣-subunit (with an insertion between motifs 2 and 3) and the C-terminal tRNA anticodon binding domain (B8) of the ␤-subunit (26). Despite
their similarity to bacterial PheRSs, the mitochondrial versions do not
contain regions analogous to the known editing domain (25). Although
it was originally suggested that mitochondrial PheRSs were active in
editing (28), later studies questioned the purity of the enzymes used for
these studies (26). Here we describe an investigation of amino acid specificity and editing by mitochondrial and cytosolic PheRSs from the yeast
Saccharomyces cerevisiae. Both enzymes display a lack of specificity
toward Phe and are able to bind Tyr. The cytosolic enzyme is shown to
be less specific than its mitochondrial counterpart but contains an editing site in the ␤-subunit that specifically edits misacylated Tyr-tRNAPhe.
The mitochondrial enzyme is deprived of such an activity and is also
able to synthesize the misaminoacylated species Tyr-tRNAPhe. Editing
activity toward Tyr-tRNAPhe is also absent from mitochondrial extracts,
indicating the lack of this quality control step in vivo. These findings are
discussed in the context of other recent studies, which together with the
data presented here, raise the possibility that mitochondrial protein
synthesis may be less accurate than its cytosolic counterpart.

EXPERIMENTAL PROCEDURES
Strains, Plasmids, and General Methods—Plasmids carrying cytosolic or mitochondrial yeast tRNAPhe genes for T7 runoff transcription

VOLUME 280 • NUMBER 46 • NOVEMBER 18, 2005

Downloaded from http://www.jbc.org/ by guest on October 29, 2020

Accurate selection of amino acids is essential for faithful translation of the genetic code. Errors during amino acid selection are
usually corrected by the editing activity of aminoacyl-tRNA synthetases such as phenylalanyl-tRNA synthetases (PheRS), which
edit misactivated tyrosine. Comparison of cytosolic and mitochondrial PheRS from the yeast Saccharomyces cerevisiae suggested that
the organellar protein might lack the editing activity. Yeast cytosolic PheRS was found to contain an editing site, which upon disruption abolished both cis and trans editing of Tyr-tRNAPhe. Wild-type
mitochondrial PheRS lacked cis and trans editing and could synthesize Tyr-tRNAPhe, an activity enhanced in active site variants with
improved tyrosine recognition. Possible trans editing was investigated in isolated mitochondrial extracts, but no such activity was
detected. These data indicate that the mitochondrial protein synthesis machinery lacks the tyrosine proofreading activity characteristic of cytosolic translation. This difference between the mitochondria and the cytosol suggests that either organellar protein synthesis
quality control is focused on another step or that translation in this
compartment is inherently less accurate than in the cytosol.

Loss of Editing from Mitochondrial PheRS
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Aminoacylation Assay with Radiolabeled tRNA—Synthesis of tRNA
P-labeled pA76 transcripts were performed essentially as described
previously (33) except that the CCA-3⬘-end was removed prior to labeling. Briefly, the CCA-3⬘-terminal nucleotides of the tRNA were first
removed by treatment of 20 M tRNA transcript with 73 g/ml Crotalus atrox venom (Sigma) in a buffer containing 40 mM sodium Gly (pH
9.0) and 10 mM magnesium acetate. The mix was incubated for 2 h at
21 °C and phenol/chloroform extracted and ethanol precipitated and
finally desalted by gel filtration through a Sephadex G 25 column
(Amersham Biosciences). The CCA-3⬘-end of the tRNA was reconstituted and radiolabeled by incubation for 10 min at 37 °C with 0.5 M
snake venom-treated tRNA in 50 mM Na-Gly (pH 9.0), 10 mM MgCl2, 10
M CTP, 9 M ATP, 1 M [␣-32P]ATP with 3 g/ml E. coli tRNAterminal nucleotidyltransferase (34) in a final volume of 20 l. The
reaction was stopped by the addition of 1 volume of phenol, and the
resulting mixture was gel filtered twice through a G25 column. As
described previously (33), the aminoacylation reaction was performed
in a 10-l aminoacylation medium (see above) containing 5 mM cold
amino acids or Phe analogues, 5 M transcript, and a trace of radiolabeled tRNA. After 15 min of incubation an aliquot was removed and
incubated for 30 min at room temperature with P1 RNase. The liberated
[␣-32P]AMP and aminoacyl-[␣-32P]AMP were separated by TLC on
polyethyleneimine cellulose and visualized as described previously (33).
Post-transfer Editing Assay—The cytosolic or mitochondrial TyrtRNAPhe and Phe-tRNAPhe (S. cerevisiae transcripts) were prepared as
described previously (25) in an aminoacylation reaction containing 30
M [3H]Tyr (180 cpm/pmol), 0.5 M mitochondrial PheRS A333G, and
5 M corresponding in vitro transcribed tRNAPhe. Comparison to the
total tRNA concentration then allowed us to estimate that purified PhetRNAPhe yields were about 20% (i.e. these preparations also contained
80% uncharged tRNA), whereas Tyr-tRNAPhe yields were 15% (85%
uncharged), within the typical range expected for aminoacyl-tRNA
preparations. Post-transfer editing reaction mixtures contained 100 mM
Na-Hepes (pH 7.2), 30 mM KCl, 10 mM MgCl2, 1 M [3H]Tyr-tRNAPhe,
and a catalytic amount of PheRS (5 nM cytosolic or 5 nM to 2 M mitochondrial yeast PheRS). The mixture was incubated at 37 °C, and the
post-transfer editing reaction was followed by measuring the remaining
radiolabeled aa-tRNA in aliquots of 15 l after 0 –12 min of incubation
as described for the aminoacylation assay (see above). The amount of
cytosolic or mitochondrial crude extract from S. cerevisiae used in the
editing assay was determined according to the PheRS specific activity
measured for the extracts, 0.78 nmol/min/mg of protein and 0.19 nmol/
min/mg of protein, respectively.
Preparation of Cytosolic and Mitochondrial Fractions of S. cerevisiae—
S. cerevisiae strain W303 was grown in rich medium containing 2% galactose, and mitochondria were isolated as described previously (35). Spheroplasts were prepared by Zymolyase-20T (ICN) treatment and broken by
three passes through an EmulsiFlex®-C5 (AVESTIN) in 0.6 M sorbitol
(Fluka), 10 mM Tris-HCl (pH 7.4), and 1 mM phenylmethylsulfonyl fluoride.
Mitochondria were purified by centrifugation and extensive washing in the
same buffer as described previously (36). The cytosolic fraction obtained
during this procedure was clarified by ultracentrifugation at 100,000 ⫻ g.
Highly purified organelles were obtained by centrifugation at 100,000 ⫻ g
(Beckman SW41) in a PercollTM step gradient (Amersham Biosciences)
(40% PercollTM in 0.6 M sorbitol (Fluka), 10 mM Tris-HCl (pH 7.4), overlaid
with 20% PercollTM in the same buffer). These procedures yielded cytosolic
and mitochondrial fractions with less than 0.5% cross-contamination as
judged by Western blot analysis with antibodies specific for proteins in the
32
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were gifts from O. Uhlenbeck (Northwestern University). The
strains Escherichia coli XL1-Blue/pQE31-FRS-ec (producing His6tagged E. coli PheRS) and E. coli BL21/pQE32-FRS-sc (producing
His6-tagged cytosolic S. cerevisiae PheRS) were gifts from D. A. Tirrell (California Institute of Technology). E. coli BL21-RIL/pET16b
producing His6-tagged mitochondrial S. cerevisiae PheRS was a gift
from R. A. Zimmermann (University of Massachusetts). All His6tagged proteins were purified to ⬎99% purity on nickel-nitrilotriacetic acid-agarose (Qiagen) by standard procedures. The specific activities of the purified proteins (nmol of Phe attached/mg/min) were:
wild-type cytoplasmic PheRS, 22; D243A cytoplasmic PheRS, 12;
wild-type mitochondrial PheRS, 89; and A333G mitochondrial
PheRS, 73. Point mutations were introduced into the pheST genes
(encoding the PheRS ␣- and ␤-subunits, respectively) by PCR with
two self-complementary 33-mer oligonucleotides that carried the
appropriate mutations. Reactions were performed with the
QuikChange site-directed mutagenesis kit (Stratagene). Introduction of the desired mutations was monitored by sequencing of the
resulting genes. Commercial L-Tyr (Sigma) was shown to be free of
phenylalanine (Phe) contamination by pyrophosphate exchange
before and after recrystallization of the amino acid as described previously (29). LB and M9 media were prepared as described previously (30).
All buffers were adjusted to the correct pH with NaOH unless otherwise
indicated. Immunoblotting was performed as described previously (31)
using rabbit polyclonal antibodies raised against yeast cytosolic PheRS
(AnimalPharm, Healdsburg, CA). tRNATrp and tryptophanyl-tRNA
synthetase were prepared as described previously (31).
Preparation of in Vitro Transcribed tRNAPhe—In vitro T7 RNA
polymerase runoff transcription reactions were conducted according to
standard procedures (32). After ethanol precipitation, tRNA transcripts
were resuspended by heating in 10 mM Hepes (pH 7.2), 1 mM EDTA,
and 7 M urea, loaded on a Resource Q 6 anion exchange column (Amersham Biosciences) and eluted with a gradient of 0 –1 M NaCl in the
loading buffer. Fractions containing tRNA were pooled and desalted on
a PD-10 column (Amersham Biosciences) against 10 mM Hepes (pH
7.2). The transcripts were ethanol precipitated, washed with 80% ethanol, dried, resuspended in 10 mM Hepes, pH 7.2, and 2 mM MgCl2, and
finally refolded by incubation for 1 min at 75 °C followed by slow cooling
down to room temperature.
ATP-PPi Exchange Reaction—The reaction was carried out at 37 °C
in a medium containing 100 mM Na-Hepes (pH 7.2), 30 mM KCl, 10 mM
MgCl2, 2 mM NaF, 2 mM ATP, 2 mM [32P]PPi (1 cpm/pmol), various
amounts of Phe (1.5–300 M) and Tyr (0.2 to 7 mM), and 13 nM cytosolic
PheRS or 10 –70 nM mitochondrial enzyme. After 1–5 min, 25 l of the
reaction were removed and added to a solution containing 1% charcoal,
5.6% HClO4, and 75 mM PPi. The radiolabeled ATP bound to the charcoal was filtered through a 3MM Whatman filter disc under vacuum
and washed three times with 5 ml of water and once with 5 ml of ethanol.
The filters were dried, and the radioactivity was counted by liquid scintillation counting (Ultima Gold, Packard Instrument Co.).
Aminoacylation Assay with Radiolabeled Amino Acids—Aminoacylation was performed in 100 mM Na-Hepes (pH 7.2), 30 mM KCl, 2 mM
ATP, 10 mM MgCl2, 25 M L-[14C]Phe (280 cpm/pmol), 5 M tRNA
transcript, and 10 –100 nM yeast PheRS. 15-l aliquots were spotted on
3MM filter disks (Whatman), washed three times in 10% trichloroacetic
acid, and dried. The amount of radioactivity retained was determined by
liquid scintillation counting. One unit of PheRS corresponded to the
amount of enzyme necessary to catalyze the formation of 1 nmol of
Phe-tRNAPhe min⫺1 mg⫺1 protein at 37 °C.

Loss of Editing from Mitochondrial PheRS
different compartments as described elsewhere (37). Mitochondria were
suspended in aminoacylation buffer (see above) followed by sonication for
1 min at 50% output with a Sonifier 450 (Branson) equipped with a microprobe. The resulting extract was centrifuged at 100,000 ⫻ g for 1 h (S100) to
precipitate the membrane fractions. The resulting soluble extracts were
used for aminoacylation assays.
Phylogenetic Analyses—179 PheRS ␣-subunit sequences (92 from
eubacteria, 23 from archaea, and 35 and 29 cytosolic and mitochondrial
eukaryotic sequences, respectively) were aligned with the ClustalX program version 1.83 (38). The alignment process was guided with the
known three-dimensional structure of PheRS of Thermus thermophilus
and refined manually. The trees were generated by applying the neighbor-joining method with the program ClustalX or the Phylip package
version 6.63 (39) to a set of 100 bootstrap replicates of the ungapped
alignment. Maximum likelihood analysis was also applied to the same
alignment with the program Puzzle version 5.2 (40) where more than
50 ⫻ 106 quartets were analyzed. The trees were rooted using the nine
known sequences of o-phosphoseryl-tRNA synthetase found in methanogenic archaea that were previously identified as paralogues of the
␣-subunit of PheRS (41).

The ␤-Subunit of Cytosolic PheRS Contains a Post-transfer Editing
Site—Previous studies (42, 43) suggested that yeast cytosolic PheRS
could hydrolyze Tyr-tRNAPhe, as recently directly demonstrated for the
E. coli enzyme (25). Tyr-tRNAPhe was synthesized and added to a deacylation reaction containing yeast cytosolic PheRS. Cytosolic PheRS was
able to specifically deacylate Tyr-tRNAPhe derived from both cytosolic
and mitochondrial tRNAs, indicating the presence of trans editing
activity (Fig. 1). Amino acid sequences from 179 PheRSs were aligned to
investigate whether this activity in the yeast enzyme could be attributed
to a catalytic site in the ␤-subunit, as is the case in E. coli. Examination of
the PheRS ␤-subunit sequence alignment allowed identification of
domains B1, B3, and B4 (B2 is absent from eukaryotes), but B3/B4 residues which are involved in bacterial editing were not well conserved in
their eukaryotic counterparts (Fig. 2). The average percentage amino
acid identities observed within eubacterial and eukaryotic B3/B4
ungapped domain alignments were 42 and 57%, respectively, whereas
there was far less similarity when eukaryotic and eubacterial B3/B4
domains were compared with each other (15% identity). No conservation was seen at the small residues Thr354 and Ala356, changes in which
ablated editing by E. coli PheRS. Moderate conservation was observed at
His265 and Glu334 (His158 and Asp243, respectively, in yeast PheRS) suggesting that those residues might contribute to the editing activity of the
cytosolic enzyme. Based on this analysis, cytosolic PheRS variants were
produced containing the replacements ␤H158A and ␤D243A.
Although the ␤H158A replacement had no effect (data not shown),
introduction of ␤D243A led to a loss in Tyr-tRNAPhe deacylation activity (Fig. 3A) similar to that observed for E. coli variants defective in
editing (25). The loss of editing but not synthetic activity resulting from
the ␤D243A replacement was confirmed by the ability of this PheRS
variant to synthesize Tyr-tRNAPhe (Fig. 3B). The misaminoacylation
activity of PheRS ␤D243A was specific for yeast cytosolic tRNAPhe, as
mitochondrial tRNAPhe was not a substrate for tyrosylation. This confirms previous indications that mitochondrial tRNAPhe could not be
phenylalanylated by cytosolic PheRS (Fig. 3C). This discrepancy
between the aminoacylation and editing capacities of mitochondrial
tRNAPhe, together with the absence of an obvious editing domain,
prompted us to investigate the organellar PheRS in more detail.

FIGURE 2. Comparison of the ␤-subunits of
eubacterial and eukaryotic PheRSs. A, modular
structure of the PheRS ␤-subunit. B, sampling of an
alignment of the B3/B4 domain regions. Positions
previously identified as being involved in the editing activity of E. coli PheRS are indicated with black
arrows. The equivalent positions found in the
yeast ␤-subunit are indicated with white arrows.
The sequence alignment (44 eubacterial and 44
eukaryotic sequences) was shaded with the program Bioedit. Gray boxes indicate 60% conservation according to similarity matrix (PAM250)based shading. Black boxes indicate residues
identical in more than 60% of the sequences.
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FIGURE 1. Specific deacylation of Tyr-tRNAPhe by yeast cytosolic PheRS. Reactions
were performed with 1 M Tyr-tRNAPhe prepared from in vitro transcribed yeast cytosolic
tRNAPhe (circles) or yeast mitochondrial tRNAPhe (triangles) with the addition of 5 nM
cytosolic PheRS (filled symbols) or in the absence of enzyme (open symbols). Values
shown are the means of three independent experiments, with error bars representing ⫾
1 S.D. The possible contribution of nonspecific nuclease activity to the observed deacylation was excluded by the finding that cytosolic PheRS did not significantly deacylate
Phe-tRNAPhe after its synthesis (see for example Fig. 3C).

RESULTS

Loss of Editing from Mitochondrial PheRS

Selectivity of the Active Sites of Mitochondrial and Cytosolic PheRS—
The specificity of the active sites of both yeast PheRSs toward Phe and
Tyr was investigated by determining the catalytic constants for steadystate amino acid activation from ATP-PPi exchange kinetics (TABLE
ONE). The mitochondrial PheRS was four times more efficient than the
cytosolic PheRS with respect to Phe activation. This was mostly because
of the 7-fold weaker apparent affinity of the cytosolic enzyme for its
substrate compared with the mitochondrial enzyme. This tendency was
reversed when Tyr was the substrate. Because Tyr exhibits poor solubility we were unable to saturate the mitochondrial enzyme. Instead, the
kcat/Km was estimated at sub-saturating concentrations of Tyr.
Although the cytosolic enzyme was twice as efficient for Tyr activation
as its mitochondrial counterpart, for both enzymes the relative efficiency of activation of Phe was only 1–2 orders of magnitude higher
than for Tyr. To determine whether such a poor apparent selectivity was

NOVEMBER 18, 2005 • VOLUME 280 • NUMBER 46
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FIGURE 3. Disruption of post-transfer editing by yeast cytosolic PheRS. A, post-transfer editing of Tyr-tRNAPhe by wild-type and variant PheRSs. Reactions were performed
with 1 M cytosolic Tyr-tRNAPhe in the presence of 5 nM enzyme. B, tyrosylation of
tRNAPhe by cytosolic PheRS. Reactions were performed with 10 M cytosolic tRNA or 3.5
M mitochondrial tRNA and 0.1 M PheRS. C, phenylalanylation of mitochondrial
tRNAPhe. Reactions were performed with 3.5 M in vitro transcribed tRNAPhe and 0.1 M
PheRS. Circle, wild-type cytosolic PheRS; triangle, editing-defective (␤D243A) cytosolic
PheRS; square, mitochondrial PheRS; diamond, without enzyme; filled symbols, cytosolic
tRNA; open symbols, mitochondrial tRNA.

because of the contamination of Tyr by a trace of Phe we assessed the
purity of the Tyr substrate by mass spectrometry (data not shown). Even
after several cycles of heating and cooling, the Tyr used for our experiments was found to be stable and free of any trace of Phe.
Specificity of Yeast Cytosolic PheRS Editing—To further define the
specificity of the editing reaction several amino acids and Phe analogues
were tested for their ability to be attached to tRNAPhe by cytosolic
PheRS and the editing-defective variant ␤D243A. The compounds used
were the 20 canonical amino acids, three intermediates of Phe metabolism (phenylpyruvate, p-hydroxyphenylpyruvate, and prephenate), and
four other Phe analogues (p-fluoro, p-chloro, p-bromo-, and p-aminoPhe) that are known to be charged but not edited by E. coli PheRS (25).
In addition to Phe, para-halogenated Phe derivatives, p-amino-Phe,
Leu, and Trp were attached to tRNA by both enzymes indicating that all
were substrates for the synthetic site of the ␣-subunit but not for the
editing site of the ␤-subunit (Fig. 4A). In the case of Trp, this supports
previous data from in vivo misincorporation experiments (44). The
␤D243A variant also synthesized Tyr-tRNAPhe indicating that this particular aminoacyl group is recognized by both the synthetic and editing
sites of PheRS (Fig. 4B).
Mitochondrial PheRS Lacks the Capacity to Edit Mischarged tRNAPhe—
To test the capacity of yeast mitochondrial PheRS to edit misaminoacylated products, Tyr-tRNAPhe was incubated with the enzyme under
conditions previously used to monitor the same activity in bacterial and
cytosolic enzymes. No significant hydrolysis of Tyr-tRNAPhe was
observed in the presence of excess enzyme, the rate of deacylation being
comparable with that seen in the absence of PheRS (Fig. 5A). These data
showed that yeast mitochondrial PheRS, in contrast to its cytosolic
counterpart, was unable to trans edit exogenous Tyr-tRNAPhe. To
probe the possibilities that mitochondrial PheRS either edits solely at
the pretransfer step or that it edits Tyr-tRNAPhe only in cis (i.e. when still
bound to PheRS), we attempted to tyrosylate tRNAPhe with the wildtype enzyme. Wild-type mitochondrial PheRS was able to stably synthesize Tyr-tRNAPhe, suggesting the absence of effective editing mechanisms in this enzyme (Fig. 5B). To investigate whether mitochondrial
PheRS contains a low level of cis editing activity not readily detectable
under the standard assay conditions, the amino acid binding pocket was
enlarged to better accommodate tyrosine as described previously (45)
for the E. coli enzyme. The resulting variant, mitochondrial PheRS
A333G, showed considerably improved Tyr-tRNAPhe synthesis compared with the wild type providing further evidence that the organellar
protein lacks editing activity (Fig. 5B). We also attempted to monitor
pretransfer editing as described previously (25) for the E. coli enzyme
but were unable to detect any significant activity for either the cytosolic
or mitochondrial enzymes (data not shown).
Trans Editing of Tyr-tRNAPhe Is Confined to Cytosolic Protein Synthesis in Yeast—Although our in vitro studies showed that mitochondrial
PheRS could not edit Tyr-tRNAPhe, it is possible that other factors might
act in trans after dissociation of the non-cognate aa-tRNA from the
enzyme. Such factors could include specific trans editing enzymes (24,
46) or cytosolic PheRS imported into yeast mitochondria as described
for other aaRSs (37). Yeast mitochondrial and cytosolic fractions were
purified as described previously (37), and the localization of PheRS was
examined in each compartment by immunoblotting (Fig. 6A). Cytosolic
PheRS was not detectable in mitochondrial extracts, suggesting that
trans editing by imported ␤-subunits would not compensate for the
absence of editing activity in the mitochondrial enzyme. The amount of
each subcellular fraction required to aminoacylate comparable amounts
of tRNAPhe with Phe was quantified (Fig. 6B), and based upon these
measurements comparable phenylalanylation activities were then incu-
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TABLE ONE

Steady-state kinetic constants for ATP-[32P]PPi exchange for cytosolic and mitochondrial PheRS from yeast
Phe

PheRS

Cytosol
Mitochondria
a
b

Tyr

KM

kcat

kcat/KM

KM

kcat

kcat/KM

M

s⫺1

s⫺1 M⫺1

M

s⫺1

s⫺1 M⫺1

30 ⫾ 2
4.2 ⫾ 0.1

240 ⫾ 40
150 ⫾ 5

8⫾2
40 ⫾ 2

860 ⫾ 300
(1700)a

160 ⫾ 40
(150)a

0.2 ⫾ 0.1
0.09 ⫾ 0.01b

Selectivity
(kcat/KM)Phe/
(kcat/KM)Tyr
40 ⫾ 30
400 ⫾ 80

Lower limits based on the assumption that the mitochondrial enzyme, like the cytoplasmic enzyme, has similar kcat values for Tyr and Phe.
Due to the high KM compared to practical Tyr concentrations ([S]⬍⬍KM), kcat/KM was directly estimated from the equation v ⫽ kcat/KM ([E][S]).

bated with different Tyr-tRNAPhe species and the rate of deacylation
monitored (Fig. 6C). The cytosolic fraction was able to rapidly deacylate
Tyr-tRNAPhe, whereas the mitochondrial extract showed no significant
difference in the rates of deacylation of Phe-tRNAPhe and Tyr-tRNAPhe.
These findings were in agreement with the in vitro data described above
and supported the notion that Tyr-tRNAPhe is not subject to proofreading and editing in yeast mitochondria.
Phylogenetic Analysis of PheRS—Phylogenetic trees were calculated
using two neighbor-joining methods and a character-based maximum
likelihood method and rooted with an alignment of o-phosphoseryltRNA synthetase sequences. All trees exhibited the same overall topology (Fig. 7), with the mitochondrial/eubacterial sequences forming one
major cluster and archaeal/eukaryotic sequences the other. In agreement with previous reports (47, 48), the only exceptions were spirochete
PheRS sequences, which clustered with the archaea, and mycoplasmataceae PheRS sequences, which clustered with the mitochondria.

DISCUSSION
Yeast Mitochondrial PheRS Is an Error-prone Enzyme—Previous
studies (26) have shown that although the two PheRSs of yeast differ
significantly in their tertiary and quaternary structures, they share similar kinetic parameters for cognate aminoacylation and are thus functionally analogous. The most significant difference between the cytoso-
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FIGURE 5. Non-cognate aminoacylation by yeast mitochondrial PheRS. A, deacylation of Tyr-tRNAPhe. Tyr-tRNAPhe was prepared using in vitro transcribed yeast mitochondrial tRNAPhe and incubated in the presence of 1 M (●) yeast mitochondrial PheRS or
without enzyme (⫻). B, aminoacylation of the mitochondrial tRNAPhe transcript (3.5 M)
with Tyr (30 M) by the mitochondrial PheRS (2 M). ●, wild-type mitochondrial PheRS; Œ,
A333G mitochondrial PheRS. The comparatively low final charging level of tRNA (10 –
30%) likely reflects reactions performed at substantially sub-saturating concentrations
of Tyr because of practical considerations.

lic and mitochondrial versions of human PheRS is a lower apparent
affinity for tRNA in the organellar enzyme (27). High-resolution crystal
structures suggested that the substantial differences between the
canonical (␣␤)2 PheRS and the mitochondrial ␣-type might not significantly impact tRNA aminoacylation, as the additional domains in the
former were presumed to have alternative non-canonical functions. For
example, the helix-turn-helix motif in domain B5 was shown to be a
bona fide DNA binding motif in T. thermophilus PheRS, capable of
binding looped double-stranded DNA (49). Deletion and mutagenesis
of B5 and other domains did not abolish the canonical activity of PheRS,
leading to the conclusion that domains 1–5 of the ␤-subunit are dispensable for efficient aminoacylation (50). One notable exception is the
B3/B4 editing domain, which is required in vitro and in vivo for the
hydrolysis of non-cognate Tyr-tRNAPhe synthesized by PheRS. No
region homologous to B3/B4 is detectable at the amino acid sequence
level in mitochondrial PheRS, and the studies described here show that
this correlates with a lack of editing activity in the enzyme. Comparison
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FIGURE 4. Substrate specificity of editing by yeast cytosolic PheRS. TLC analysis of the
aminoacylation of tRNAPhe with various amino acids and Phe analogues by the wild-type
cytosolic PheRS (A) and the editing-defective variant ␤D243A PheRS (B). TLC analysis of
the aminoacylation of tRNATrp with Trp by tryptophanyl-tRNA synthetase (C). No aa, no
amino acid.
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FIGURE 7. Phylogenetic analysis of PheRS ␣-subunits (A) and comparison of the
organization of eubacterial and mitochondrial PheRS genes (B). Black squares, dark
gray squares, and light gray squares indicate nodes found in ⬎95%, ⬎85%, and ⬎65%,
respectively, of the trees generated by neighbor-joining or maximum likelihood analysis.
A single recombination event (dashed line) involving the eubacterial ␣,␤-subunit operon
might be at the origin of the fused ␣,␤ mitochondrial PheRS.

of Phe and Tyr activation by the cytosolic and mitochondrial enzymes
showed only modest differences in substrate specificities, indicating
that both enzymes have significant capacities for non-cognate aminoacylation. Previous studies (51) have shown that Tyr and Phe are likely
present at comparable levels in mitochondria and the cytosol, indicating
that the likelihood of non-cognate amino acid activation by PheRS will
not be affected by subcellular localization. For the cytosolic enzyme, the
existence of an editing mechanism ensures that any errors in amino acid
activation do not affect the overall accuracy of the aminoacylation reaction. No such editing mechanism exists, either in cis or trans, during
mitochondrial phenylalanylation, and the organellar PheRS can be considered an error-prone enzyme. Other aaRSs, such as certain ProRSs
(46, 52) and ThrRSs (21), have also been shown to have natural uncorrected mischarging activities that result in non-cognate aminoacyltRNA synthesis. However, in both cases the enzymes are not considered
error-prone, as they associate with other proteins that ensure non-cognate aminoacyl-tRNAs are rapidly edited (53). Mitochondrial PheRS is
markedly different in that no detectable editing activity is associated
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FIGURE 6. Aminoacylation and post-transfer editing by yeast mitochondrial and
cytosolic fractions. A, immunodetection of PheRS in cytosolic and mitochondrial fractions. 20 g of protein from mitochondrial and cytosolic fractions was subjected to
SDS/PAGE, and the PheRSs were subsequently detected by immunoblotting using rabbit anti-yeast cytosolic PheRS antibodies. This allowed detection of mitochondrial PheRS
(␣m) and both subunits of the cytosolic PheRS (␣c and ␤c) as indicated by the corresponding arrows. Lanes: 1, mitochondrial fraction; 2, cytosolic fraction. B, phenylalanylation
activity. Aminoacylation of the cytosolic tRNAPhe transcript (5 M) was performed with
Phe (30 M) by the mitochondrial (160 g of protein/ml) (Œ) or cytosolic (180 g of
protein/ml) (●) fractions. C, post-transfer editing of Tyr-tRNAPhe. Tyr-tRNAPhe (black) or
Phe-tRNAPhe (gray) was prepared using in vitro transcribed yeast cytosolic or mitochondrial tRNAPhe and incubated, respectively, with the same amounts of cytosolic (circles) or
mitochondrial (triangles) crude extracts as used in B.

with it, suggesting amino acid specificity was lost during evolution from
more accurate ancestral proteins.
Loss of the Editing Subdomain during Evolution of Mitochondrial
PheRS—Previous analyses (47, 48) based upon alignments of PheRS
␣-subunit amino acid sequences indicated a canonical phylogeny for
this protein family, with the only significant horizontal gene transfer
being observed in the spirochetes. The updated analysis described here
provides a similar phylogenetic tree composed of monophyletic
archaeal/eukaryotic and bacterial clusters, with the mitochondrial
PheRSs forming a single, distinct subgroup within the latter (Fig. 7).
These data suggest a single bacterial origin for extant mitochondrial
PheRSs but provide few clues on the subsequent evolution of the
organellar protein. The widespread retention of a discrete full-length
␤-subunit indicates that editing activity was lost after separation of the
mitochondrial proteins. In addition to the absent B3/B4 editing module,
mitochondrial PheRSs lack the B5 DNA binding domain, B6/B7 oligomerization domain, and B2 EMAP domain, suggesting that loss of
editing may have been part of a broader process whereby numerous
functions dispensable for protein synthesis were lost during evolution of
the organellar protein. This loss of function is, to date, limited to mitochondria, as chloroplast PheRSs are of the (␣␤)2 type and contain an
intact B3/B4 domain (54).
Editing of Misacylated tRNAs in Mitochondria—The loss of editing
function from mitochondrial PheRS is particularly striking because it
was accompanied by a significant change in the oligomeric state of the
protein. Less dramatic changes were also shown to lead to a loss of
editing function from human mitochondrial LeuRS, which is able to
stably synthesize Ile-tRNALeu in vitro (55). The editing function of
LeuRS is contained in the highly conserved CP1 domain (56, 57), but key
residues in this region necessary for hydrolysis of non-cognate aminoacyl-tRNA have diverged during evolution leading to a loss of function
from the mitochondrial protein. Although it is unclear whether other
factors act in trans to compensate for the lack of editing by mitochondrial LeuRS, the evolutionary trend toward a more error-prone aaRS
mirrors that described above for PheRS. This, in turn, raises the question as to whether other mitochondrial aaRSs might also lack the capacity to edit misaminoacylated tRNAs. For example, mitochondrial ThrRS
lacks either of the modules known to edit Ser-tRNAThr (19 –21) suggesting that this misacylated species might also escape hydrolysis. However,
Ser-tRNAThr can be directly hydrolyzed by free-standing editing
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domains acting in trans emphasizing the need for direct experimental
confirmation that particular editing pathways are absent from
mitochondria.
The absence of certain aaRS editing reactions from mitochondria
suggests that the need for fidelity during aminoacyl-tRNA synthesis
may be lower in this compartment than in the cytosol, perhaps accelerating the loss of these energetically costly secondary activities. Loss of
the editing domain from mitochondrial PheRS is in stark contrast to the
general pattern of synthetase evolution, where modules with new functionality have been systematically integrated into extant proteins (58).
This fundamental difference between mitochondrial and cytosolic aaRS
evolution and function indicates that either organellar protein synthesis
quality control is focused on another step or that translation in this
compartment is inherently less accurate. From a physiological standpoint, reduced accuracy during translation might not be as detrimental
in the mitochondrial system, where only a small number of proteins are
encoded. In the presence of an efficient protein degradation machinery,
it is not unlikely that the bulk of the mitochondrial quality control
occurs post-translationally at the level of protein stability as has been
recently shown (see for example Ref. 59 and references therein). In this
respect, only folded proteins that can join an active respiratory complex
are protected from degradation. Mistakes in any protein subunit resulting from reduced translational accuracy can be easily accommodated by
very rapid protein degradation. This model could be easily re-enforced
by measuring translational accuracy with mitochondrial ribosomes and
comparing the error rate to that of degradation. However, currently in
vitro translation systems with mitochondrial ribosomes have not been
established, and this will thus remain an open question.
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